Overview
Fengxi Su practices in Guangzhou, China. Su is rated as a Distinguished expert by MediFind in the treatment of Breast Cancer. Their top areas of expertise are Breast Cancer, Breast Cancer in Men, Adenoid Cystic Carcinoma, Mastectomy, and Lymphadenectomy.
Their clinical research consists of co-authoring 116 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 102 articles and participated in 1 clinical trial in the study of Breast Cancer.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Breast CancerSu isDistinguished. Learn about Breast Cancer.
- Advanced
- Breast Cancer in Men
- MastectomySu isAdvanced. Learn about Mastectomy.
- Experienced
- Adenoid Cystic Carcinoma
- AgranulocytosisSu isExperienced. Learn about Agranulocytosis.
- Breast InfectionSu isExperienced. Learn about Breast Infection.
- Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome)
- Febrile NeutropeniaSu isExperienced. Learn about Febrile Neutropenia.
- LymphadenectomySu isExperienced. Learn about Lymphadenectomy.